Schematic on the left depicts Insulin/Tor signalling pathway, where the components manipulated are labelled with numbers and are referred to below.
-
A, B
Fat body from animals expressing mCherry
RNAi
or TOR
DN
(1) under the control of CG‐GAL4, with TGF‐ß signalling activation indicated by pMad staining.
-
C
Quantification of normalised pMad (to DAPI) staining in (A, B). mCherry
RNAi
(n = 21), TOR
DN
(n = 14).
-
D, E
Fat body from animals expressing mCherry
RNAi
or 4E‐BP
CA
(4) under the control of CG‐GAL4, with TGF‐ß signalling activation indicated by pMad staining.
-
F
Quantification of normalised pMad staining in (D, E). mCherry
RNAi
(n = 15), 4E‐BP
CA
(n = 15).
-
G, H
Fat body from animals expressing mCherry
RNAi
or S6K
CA
(2) under the control of CG‐GAL4, with TGF‐ß signalling activation indicated by pMad staining.
-
I
Quantification of normalised pMad staining in (G, H). mCherry
RNAi
(n = 20), S6K
CA
(n = 30).
-
J, K
Fat body from animals expressing mCherry
RNAi
or FOXO (3) under the control of CG‐GAL4, with TGF‐ß signalling activation indicated by pMad staining.
-
L
Quantification of normalised pMad staining in (J, K). mCherry
RNAi
(n = 30), FOXO (n = 30).
-
M–P
Fat body from animals expressing
mCherry
RNAi
or
Tor
DN
(1) or InR
CA
;
mCherry
RNAi
(5) or
InR
CA
;Tor
DN
(5,
1) under the control of
r4‐GAL4, with TGF‐ß signalling activation indicated by pMad staining (the same
mCherry
RNAi
sample was used in Fig
8A, as these experiments were carried out together).
-
Q
Quantification of normalised pMad staining in (M–P).
mCherry
RNAi
(
n = 16),
Tor
DN
(
n = 20),
InR
CA
;
mCherry
RNAi
(
n = 12),
InR
CA
;Tor
DN
(
n = 16). The same
mCherry
RNAi
and
InR
CA
;
mCherry
RNAi
data points were used as in Fig
8F.